Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;114:e627
doi: 10.1161/CIRCULATIONAHA.106.656611
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bleiziffer, S.
Right arrow Articles by Lange, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bleiziffer, S.
Right arrow Articles by Lange, R.
Related Collections
Right arrow Echocardiography
Right arrow CV surgery: aortic and vascular disease

(Circulation. 2006;114:e627.)
© 2006 American Heart Association, Inc.


Correspondence

Letter by Bleiziffer et al Regarding Article, "Long-Term Outcomes After Valve Replacement for Low-Gradient Aortic Stenosis: Impact of Prosthesis-Patient Mismatch"

Sabine Bleiziffer, MD; Walter Benno Eichinger, MD; Ruediger Lange, PhD, MD

Clinic for Cardiovascular Surgery, German Heart Center Munich, Munich, Germany, bleiziffer@dhm.mhn.de


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

To the Editor:

With great interest, we read the article by Kulik and associates1 identifying patient-prosthesis mismatch (PPM) (defined as an effective orifice area [EOA] index below 0.85 cm2/m2) as an independent predictor of a higher incidence of congestive heart failure and impaired left ventricular mass regression after aortic valve replacement in patients with low-gradient aortic stenosis. In the study by Kulik et al, PPM was assessed by reference tables, although echocardiographic EOA index data were also available.

When analyzing large patient populations to investigate the impact of PPM on clinical outcome, echocardiographic EOA index data are often not available, and the EOA is only estimated by reference tables (based on echo or in vitro data) or by the use of the geometric orifice area, which is a fixed geometric parameter derived from the internal prosthesis diameter. One must be aware that these methods cannot detect all patients with severe or moderate PPM, and there are false-positive and false-negative categorizations. Pibarot et al2 demonstrated that the sensitivity and specificity to detect PPM are 73% and 80% when using echocardiographically derived reference tables (as done by Kulik et al1). Blackstone and associates3 used a geometric orifice area of <1.1 cm2/m2 to define "a prosthesis too small for patient size" and found no impact on long-term mortality. The indexed geometric valve area has been shown to be unrelated to hemodynamics or clinical outcomes.4

Hence, estimations of PPM based on reference tables and on the geometric orifice area yield . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
CirculationHome page
D. J. Ruzicka, I. Hettich, A. Hutter, S. Bleiziffer, C. C. Badiu, R. Bauernschmitt, R. Lange, and W. B. Eichinger
The Complete Supraannular Concept: In Vivo Hemodynamics of Bovine and Porcine Aortic Bioprostheses
Circulation, September 15, 2009; 120(11_suppl_1): S139 - S145.
[Abstract] [Full Text] [PDF]